{"title":"Revascularization in Ischemic Left Ventricular Dysfunction: From Risk to Reality","authors":"Bjorn Redfors MD, PhD , Sandeep Jha MD , Elmir Omerovic MD, PhD","doi":"10.1016/j.jscai.2025.103874","DOIUrl":"10.1016/j.jscai.2025.103874","url":null,"abstract":"","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 9","pages":"Article 103874"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145098891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mohammadreza Naderian MD, MPH , Jun Li MD , Yulanka Castro-Dominguez MD , Tarek Hammad MD , Clint Oommen MD , Herbert D. Aronow MD, MPH , Eric A. Secemsky MD, MSc , Mehdi H. Shishehbor DO, MPH, PhD
{"title":"Impact of COVID-19 Pandemic on Treatment and Outcome of Patients With Femoropopliteal Peripheral Arterial Disease","authors":"Mohammadreza Naderian MD, MPH , Jun Li MD , Yulanka Castro-Dominguez MD , Tarek Hammad MD , Clint Oommen MD , Herbert D. Aronow MD, MPH , Eric A. Secemsky MD, MSc , Mehdi H. Shishehbor DO, MPH, PhD","doi":"10.1016/j.jscai.2025.103816","DOIUrl":"10.1016/j.jscai.2025.103816","url":null,"abstract":"","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 9","pages":"Article 103816"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145099340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rafael Gomes MD, MSc, PhD, Jorge Guimarães MD, MSc, PhD
{"title":"Revisiting Prinzmetal Legacy: The Structural Determinants of Coronary Spasm in Angina and Nonobstructive Coronary Arteries","authors":"Rafael Gomes MD, MSc, PhD, Jorge Guimarães MD, MSc, PhD","doi":"10.1016/j.jscai.2025.103862","DOIUrl":"10.1016/j.jscai.2025.103862","url":null,"abstract":"","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 9","pages":"Article 103862"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145098708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Edmond M. Cronin MB BCh BAO , Steven Filby MD, FSCAI , Michael E. Field MD , Chetan Huded MD, FSCAI , Julia H. Indik MD, PhD , Abhishek Sharma MD, FSCAI , Chelsea Armah MPH , Scott Firestone MS , Angela M. Fix MPH, MCW , Emily Senerth MS, MPH , Rebecca L. Morgan PhD, MPH , Yngve Falck-Ytter MD
{"title":"SCAI/HRS Technical Review on Transcatheter Left Atrial Appendage Occlusion","authors":"Edmond M. Cronin MB BCh BAO , Steven Filby MD, FSCAI , Michael E. Field MD , Chetan Huded MD, FSCAI , Julia H. Indik MD, PhD , Abhishek Sharma MD, FSCAI , Chelsea Armah MPH , Scott Firestone MS , Angela M. Fix MPH, MCW , Emily Senerth MS, MPH , Rebecca L. Morgan PhD, MPH , Yngve Falck-Ytter MD","doi":"10.1016/j.jscai.2025.103784","DOIUrl":"10.1016/j.jscai.2025.103784","url":null,"abstract":"<div><h3>Background</h3><div>Nonvalvular atrial fibrillation (NVAF) is associated with an increased risk of stroke due to thrombus formation in the left atrial appendage, where over 90% of thrombi originate. While oral anticoagulation (OAC) is the standard therapy for stroke prevention, many patients cannot tolerate long-term OAC due to bleeding risks. Percutaneous left atrial appendage occlusion (LAAO) has emerged as an alternative strategy. Despite its rapid adoption, substantial variability exists in clinical practice regarding patient selection, imaging techniques, procedural guidance, and postprocedural management. This systematic review aims to collect and synthesize evidence to inform the development of new Society for Cardiovascular Angiography & Interventions (SCAI) and the Heart Rhythm Society (HRS) guidelines on LAAO.</div></div><div><h3>Methods</h3><div>We searched PubMed, Embase, and Cochrane Library from inception through January 5, 2024, for studies of the percutaneous LAAO procedure. Eligible studies were conducted in adults with NVAF undergoing LAAO, or with peridevice leak or device-related thrombus after an occlusion procedure. Studies of surgical LAAO, double device or combined procedures, and devices that are not currently marketed in the United States were excluded. Data were extracted from studies in duplicate and summarized using meta-analysis and narrative synthesis. Risk of bias (RoB) was assessed using the RoB in nonrandomized studies of interventions tool, and version 2 of the Cochrane RoB tool for randomized trials (RoB 2.0). Overall certainty of evidence was assessed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach.</div></div><div><h3>Results</h3><div>Our search identified 3769 titles and abstracts, of which 27 studies met eligibility criteria and contributed data to the analysis. Data were abstracted to address outcomes of LAAO for stroke prevention in patients with NVAF, in comparison to OAC, no therapy, and across various approaches including preprocedure imaging, intraprocedure guidance, and postprocedure antithrombotic regimens.</div></div><div><h3>Conclusions</h3><div>Left atrial appendage occlusion is an effective alternative to OAC for stroke prevention in NVAF patients with bleeding risks, but uncertainties remain regarding imaging strategies and postprocedural management.</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 9","pages":"Article 103784"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145098710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Left Atrial Appendage Occlusion: Persistent Gaps","authors":"William A. Gray MD","doi":"10.1016/j.jscai.2025.103864","DOIUrl":"10.1016/j.jscai.2025.103864","url":null,"abstract":"","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 9","pages":"Article 103864"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145098711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sarosh P. Batlivala MD, MSci, FSCAI , Dana Boucek MD , Tacy Downing MD , Timothy Head DO , Carrie Herbert MD, FSCAI , Philip Levy MD , R. Allen Ligon MD, FSCAI , Souvik Mitra MD , Arash Salavitabar MD, FSCAI , Shyam Sathanandam MD, FSCAI , Nathaniel Taggart MD, FSCAI , Jenny Zablah MD, FSCAI , Evan Zahn MD, MSCAI , Brent M. Gordon MD, FSCAI
{"title":"SCAI Position Statement on Transcatheter Occlusion of Patent Ductus Arteriosus in Premature Infants","authors":"Sarosh P. Batlivala MD, MSci, FSCAI , Dana Boucek MD , Tacy Downing MD , Timothy Head DO , Carrie Herbert MD, FSCAI , Philip Levy MD , R. Allen Ligon MD, FSCAI , Souvik Mitra MD , Arash Salavitabar MD, FSCAI , Shyam Sathanandam MD, FSCAI , Nathaniel Taggart MD, FSCAI , Jenny Zablah MD, FSCAI , Evan Zahn MD, MSCAI , Brent M. Gordon MD, FSCAI","doi":"10.1016/j.jscai.2025.103866","DOIUrl":"10.1016/j.jscai.2025.103866","url":null,"abstract":"<div><div>Historically, pharmacotherapy and surgical ligation have been the primary treatments for occlusion of patent ductus arteriosus (PDA), but recent advancements have led to the US Food and Drug Administration approval of the first transcatheter PDA occlusion device for low birth weight infants in 2019. Although short-term outcomes have been encouraging, successful outcomes are highly dependent on proper patient selection, awareness of key procedural considerations, appropriately trained operators, and institutions meeting a standard of required infrastructural requirements. A multidisciplinary approach involving neonatologists and cardiologists is beneficial, as well as shared decision-making with the patient’s family. This position statement from the Society for Cardiovascular Angiography & Interventions provides comprehensive suggestions to optimize the safety and efficacy of transcatheter PDA occlusion in premature infants, aiming to improve long-term outcomes in this vulnerable population.</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 9","pages":"Article 103866"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145098878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ralf J. Holzer MD , Brian Quinn MD , Shawn Batlivala MD , Lisa Bergersen MD , Ben Blais MD , Brian Boe MD , Lindsay F. Eilers MD , Howaida El-Said MD , Susan Foerster MD , Kimberlee Gauvreau ScD , Michael Hainstock MD , Babar Hasan MD , George Nicholson MD , Sara M. Trucco MD , Michael L. O’Byrne MD, MSCE
{"title":"Prolonged Length of Stay After Elective Same-Day Admissions for Pediatric or Congenital Cardiac Catheterizations: A Potential Measure for Procedural Harm","authors":"Ralf J. Holzer MD , Brian Quinn MD , Shawn Batlivala MD , Lisa Bergersen MD , Ben Blais MD , Brian Boe MD , Lindsay F. Eilers MD , Howaida El-Said MD , Susan Foerster MD , Kimberlee Gauvreau ScD , Michael Hainstock MD , Babar Hasan MD , George Nicholson MD , Sara M. Trucco MD , Michael L. O’Byrne MD, MSCE","doi":"10.1016/j.jscai.2025.103804","DOIUrl":"10.1016/j.jscai.2025.103804","url":null,"abstract":"<div><h3>Background</h3><div>Although adverse events (AEs) are common during congenital cardiac catheterization procedures, many have little impact beyond the catheterization laboratory. We sought to identify factors that are associated with an increased length of stay (LOS).</div></div><div><h3>Methods</h3><div>A total of 10,882 cases from the C3PO-quality improvement registry dataset from January 2014 to December 2017 admitted electively on the same day of cardiac catheterization were analyzed and independent risk factors for a prolongation of LOS were identified.</div></div><div><h3>Results</h3><div>Length of stay ranged from 0 to 305 days. The incidence of higher severity AE was significantly higher for cases that had a hospital stay of 2 days or more, compared to those discharged the same day or day 1 after the procedure (15% vs 2%, <em>P</em> < .001). Seven percent of patients without any AE in the cardiac catheterization laboratory had a prolonged LOS of 2 days or more. Significant independent risk factors for a prolongation of LOS included age <1 year, single ventricle diagnosis, cardiac surgery within the last 90 days, a higher hemodynamic vulnerability score, a higher PREDIC<sup>3</sup>T risk category, a prolonged procedure time, contrast usage >6 mL/kg, operators experience of either <5 or ≥25 years, and operator case volume >200 cases/y. The presence of any level 3bc, 4, or 5 AE had the highest associated odds of an increased LOS (OR, 5.9; 95% CI, 4.6-7.6).</div></div><div><h3>Conclusions</h3><div>Prolonged admission after outpatient catheterization is a potential alternative measure of safety after pediatric or congenital cardiac catheterization. It is independently associated not only with patient, procedure, and operator factors that have previously been described to be associated with the risk of AE but also with other factors such as the presence of single ventricle physiology. Further studies are needed to further evaluate its utility.</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 9","pages":"Article 103804"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145098885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Avram R.P. Rago MD , John Wiegand MD , James A. Thompson MD
{"title":"Successful Use of the ŌNŌ Retrieval Device for Stent Removal in a High-Risk Pediatric Patient: Case Report","authors":"Avram R.P. Rago MD , John Wiegand MD , James A. Thompson MD","doi":"10.1016/j.jscai.2025.103812","DOIUrl":"10.1016/j.jscai.2025.103812","url":null,"abstract":"<div><div>The management of misplaced or embolized devices within the cardiovascular system is critical in interventional cardiology. While uncommon, embolized material can cause significant morbidity. The ŌNŌ retrieval device has been used for retrieval of endovascular material in adults and pediatric patients. In this report, we describe the youngest patient to date who has undergone endovascular material removal using the ŌNŌ device.</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 9","pages":"Article 103812"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145098886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Zachary D. Demertzis DO, Terry R. Bowers MD, James A. Goldstein MD
{"title":"Determinants of Right Ventricular Performance in Severe Acute Pulmonary Embolism","authors":"Zachary D. Demertzis DO, Terry R. Bowers MD, James A. Goldstein MD","doi":"10.1016/j.jscai.2025.103868","DOIUrl":"10.1016/j.jscai.2025.103868","url":null,"abstract":"<div><h3>Background</h3><div>Severe acute pulmonary embolism (PE) induces hemodynamic compromise due to a failing right ventricle (RV) and a “dry” hyperdynamic left ventricle (LV). RV systolic dysfunction is the key parameter to determine acute PE risk stratification, clinical management, and prognosis. The present study delineates the determinants of RV performance in acute PE resulting in RV dysfunction.</div></div><div><h3>Methods</h3><div>This was a single-center, retrospective analysis of a high-volume PE response team database of patients with intermediate-high-risk or high-risk PE with an echocardiogram prior to escalation of care.</div></div><div><h3>Results</h3><div>The RV free wall motion (total RVFW motion score = 8.1 ± 2.8) was correlated with the magnitude of RV systolic depression (RV fractional area change [FAC] = 29 ± 13%, tricuspid annular planar systolic excursion = 1.57 ± 0.49 cm, and S′ velocity = 10.57 ± 3.14 cm/s). LV preload and stroke volume were markedly reduced (LV end diastolic size = 4.04 ± 0.68 cm and volume = 73.6 ± 25.8 mL; LV stroke volume = 46.2 ± 16.6 mL). LV preload deprivation was correlated with the severity of RV systolic dysfunction (total RVFW motion score, <em>r</em> = −0.11, <em>P</em> = .39; FAC, <em>r</em> = 0.25, <em>P</em> = .04; S′ velocity, <em>r</em> = 0.27, <em>P</em> = .03). RV overload induced reversed interventricular septal curvature reflected by LV end diastolic eccentricity index = 1.21 ± 0.21, which correlated with RV systolic dysfunction (total RVFW motion score, <em>r</em> = 0.47, <em>P</em> < .001; FAC, <em>r</em> = −0.35, <em>P</em> < .005; S′ velocity, <em>r</em> = −0.43, <em>P</em> < .001) and RV dilation.</div></div><div><h3>Conclusions</h3><div>Afterload strain imposed by PE may induce severe RV systolic dysfunction attributable to marked RVFW dysfunction. RV systolic pressure generation and transpulmonary flow are generated through systolic ventricular interactions mediated by primary septal contraction and paradoxical septal motion.</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 9","pages":"Article 103868"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145099336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gurumurthy Hiremath MD , Juan Carlos Samayoa MD , Alexander Javois MD , Osamah Aldoss MBBS, MD , Ryan Leahy MD, MA , Reid Chamberlain MD, MSCI , Elena Amin MD , Marko Vezmar MD , Makram Ebeid MD , Shyam Sathanandam MD , David Nykanen MD , Thomas Forbes MD , Christopher Curzon MD , Martin Bocks MD , Daisuke Kobayashi MD, MPH, MHA
{"title":"Trends in Radiation Exposure With the Refinement of Radiation Exposure Categories in Congenital Cardiac Catheterization: Insights From the CRISP Registry","authors":"Gurumurthy Hiremath MD , Juan Carlos Samayoa MD , Alexander Javois MD , Osamah Aldoss MBBS, MD , Ryan Leahy MD, MA , Reid Chamberlain MD, MSCI , Elena Amin MD , Marko Vezmar MD , Makram Ebeid MD , Shyam Sathanandam MD , David Nykanen MD , Thomas Forbes MD , Christopher Curzon MD , Martin Bocks MD , Daisuke Kobayashi MD, MPH, MHA","doi":"10.1016/j.jscai.2025.103727","DOIUrl":"10.1016/j.jscai.2025.103727","url":null,"abstract":"<div><h3>Background</h3><div>The Congenital Cardiac Catheterization Project on Outcomes (C3PO) registry proposed 3-tier radiation exposure categories (REC: I [low], II [medium], and III [high]) consisting of 40 procedure types. This study sought to evaluate the recent trend of radiation exposure in the Catheterization Risk Score for Pediatrics (CRISP) registry organized by the Congenital Cardiovascular Interventional Study Consortium.</div></div><div><h3>Methods</h3><div>The analysis was conducted on a comprehensive data set from the CRISP registry, covering 13 institutions from January 1, 2016, to December 31, 2020. Radiation dosage in μGym<sup>2</sup>/kg was evaluated by REC, time, and institutions. The study period was divided into the first half (S1: 1/2016-6/2018) and the second half (S2: 7/2018-12/2020). Radiation dosage was compared between S1 and S2. Radiation reduction practices were assessed at participating centers through a questionnaire.</div></div><div><h3>Results</h3><div>Among 20,524 cases, the majority (n = 18,603, 90.2%) were assigned to C3PO REC procedure types. From S1 (n = 8956) to S2 (n = 9647), median radiation dosage significantly improved in all 3 tiers (<em>P</em> < .001): (1) REC I, −18%; (2) REC II, −33%; and (3) REC III, −30%. REC successfully stratified cases by median radiation dosage: (1) REC I, 18.2 μGym<sup>2</sup>/kg (n = 14,234); (2) REC II, 49.8 μGym<sup>2</sup>/kg (n = 3012); and (3) REC III, 67.0 μGym<sup>2</sup>/kg (n = 1357) but showed significant intraclass variability and heterogeneity. REC I exhibited the most variability in radiation dosage. To address these limitations, the procedures were organized into 6 updated REC categories (CRISP REC).</div></div><div><h3>Conclusions</h3><div>A significant reduction in radiation dosage was observed in the CRISP registry, although a few centers showed a trend of increasing radiation dosage. Despite its limitations, the C3PO REC provides a practical way to stratify cases for reporting dosage. We propose the CRISP REC as a refined alternative to the C3PO REC to improve stratification and decrease variability in radiation exposure across different categories.</div></div>","PeriodicalId":73990,"journal":{"name":"Journal of the Society for Cardiovascular Angiography & Interventions","volume":"4 8","pages":"Article 103727"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144864379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}